Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2003
11/20/2003WO2003020756A3 Hybrid and tandem expression of neisserial proteins
11/20/2003WO2003008638A3 Sorting and immobilization system for nucleic acids using synthetic bidning systems
11/20/2003WO2002088396A3 Reagents and methods for automated in situ or microarray hybridization
11/20/2003WO2002072825A3 Human mrp5-like protein
11/20/2003WO2002061110A8 Nucleic acid derivatives
11/20/2003WO2002055547A3 Sfrp and peptide motifs that interact with sfrp and methods of their use
11/20/2003US20030216562 Genetic engineered polypeptides; binding to antibodies; recovering culture product
11/20/2003US20030216561 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216560 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216347 Genetic material composed of a polynucleotide complexed with an amphipathic compound, a polymer or a nonviral vector is delivered to the parenchymal cell altering its endogenous properties
11/20/2003US20030216346 Gene carrier
11/20/2003US20030216339 Gene sequences associated with neural plasticity and methods related thereto
11/20/2003US20030216335 Treating endometriosis by contacting the subject with a nucleic acid that modulates the expression of VEGF, VEGFR1, and/or VEGFR2
11/20/2003US20030216334 Oligodeoxynucleotides consisting of 4-thio-2'-deoxyuridylate units
11/20/2003US20030216333 Antisense modulation of glycogen synthase kinase3 alpha expression
11/20/2003US20030216322 Containing the motif E(L/V/S)RGDS
11/20/2003US20030216318 Inhibition of transmission of tick-borne infections
11/20/2003US20030216317 Protein having cell-recognizing activity and/or cytocidal activity
11/20/2003US20030216305 Identification and characterization of a polypeptide having homology to the sarcoma-amplified protein SAS
11/20/2003US20030215950 Isolated polynucleotides and methods of promoting a morphology in a fungus
11/20/2003US20030215949 Dehydroascorbate reductase ("DHAR") genes and their uses
11/20/2003US20030215943 Antisense modulation of apolipoprotein B expression
11/20/2003US20030215930 Genes involved in cyclododecanone degradation pathway
11/20/2003US20030215922 Comprises genetically engineered metallothionein-streptavidin fusion protein for use as diagnostic tool; preventative in therapeutic medicine
11/20/2003US20030215917 Compositions and methods for quantification of extent of replication of Hepatitis C viral genome in an in vitro tissue culture system, in particular, replicon assay for identifying drug substances in high throughput screening format
11/20/2003US20030215912 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
11/20/2003US20030215911 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215910 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215907 Comprise nucleotide sequences coding enzymatic polypeptide for use as modification and selection tools in genetic engineering
11/20/2003US20030215904 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents
11/20/2003US20030215896 Gamma secretase substrates and in vitro assays
11/20/2003US20030215893 Nucleic acids, proteins, and antibodies
11/20/2003US20030215862 Comprises nucleotide analogs comprising phosphate carbamate groups; microfluidics
11/20/2003US20030215860 G-protein coupled receptors for diagnosis, prevention and treatment of nervous system, cell proliferative, pain, metabolic, hormonal kidney and brain disorders
11/20/2003US20030215856 Synthetic microarray comprising immobilized DNA for detection of modulators of protein binding activity; high throughput assay
11/20/2003US20030215853 Amination, dehydroxylation; for hybridization of DNA
11/20/2003US20030215836 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
11/20/2003US20030215835 Designing oligonucleotides for diagnosing, monitoring, prognosticating, preventing or treating metabolic disorders; forensics; gene therapy; drug screening
11/20/2003US20030215833 Variant cleavage stimulation factor and its encoding nucleic acid
11/20/2003US20030215828 Gene markers for lung cancer
11/20/2003US20030215827 Comprises enzymatic polypeptide for use in diagnosis, treatment and prevention of cell proliferative and autoimmune/inflammatory disorders
11/20/2003US20030215826 Labeled oligonucleotides for use as diagnostic tools in nucleic acid replication
11/20/2003US20030215820 Regulators of type-1tumor necrosis factor receptor and other cytokine receptor shedding
11/20/2003US20030215818 Method for nucleic acid extraction and nucleic acid purification
11/20/2003US20030215817 Modulation of gene expression in formation of fatty atherosclerotic lesions
11/20/2003US20030215812 Gene encoding beta-mannanase, enzyme preparation and uses thereof
11/20/2003US20030215801 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
11/20/2003US20030215789 Method and kit for detecting white spot syndrome virus
11/20/2003US20030215489 Chemosensitizing with liposomes containing oligonucleotides
11/20/2003US20030215427 CE7-specific redirected immune cells
11/20/2003US20030215421 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
11/20/2003CA2823041A1 Fgf variants and methods for use thereof
11/20/2003CA2805053A1 Pyrophosphorolysis activated polymerization (pap)
11/20/2003CA2487236A1 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
11/20/2003CA2483930A1 Methods for the enrichment of low-abundance polynucleotides
11/20/2003CA2483698A1 Cytokine polypeptides
11/20/2003CA2483602A1 Fgf variants and methods for use thereof
11/20/2003CA2460679A1 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith
11/19/2003EP1362916A2 Human tumor necrosis factor delta and epsilon
11/19/2003EP1362862A1 Dinucleotide crystals
11/19/2003EP1362124A1 Methods and probes for the detection of cancer
11/19/2003EP1362121A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/19/2003EP1362113A2 Constitutive promoter from arabidopsis
11/19/2003EP1202998B1 Synthesis of stable quinone and photoreactive ketone phosphoramidite reagents for solid phase synthesis of photoreactive-oligomer conjugates
11/19/2003EP0901500B1 In situ preparation of nucleoside phosphoramidites and their use in synthesis of oligonucleotides
11/19/2003CN1456670A Genes of resveratrol stilbene synthase in parthenocissus and their use
11/18/2003US6649769 For labelling a polynucleotides
11/18/2003US6649750 Process for the preparation of oligonucleotide compounds
11/18/2003US6649749 Oligonuclelotide mix for use in the detection and treatment of viral diseases
11/18/2003US6649598 4,7-dichlorofluorescein dyes as molecular probes
11/18/2003US6649409 Method for producing a nucleotide sequence construct with optimized codons for an HIV genetic vaccine based on a primary, early HIV isolate and synthetic envelope BX08 constructs
11/18/2003US6649378 Self-contained device integrating nucleic acid extraction, amplification and detection
11/18/2003US6649351 Methods for detecting a plurality of analytes by mass spectrometry
11/18/2003US6649347 Use of methylated nucleic acid segments for isolating centromere DNA
11/13/2003WO2003094088A1 Mouse olfactory receptor gene superfamily specification
11/13/2003WO2003093512A1 Methods and compositions for the modification of nucleic acids
11/13/2003WO2003093471A1 Novel 88 phage vectors
11/13/2003WO2003093452A2 Variants of nedd4l associated with hypertension and viral budding
11/13/2003WO2003092869A1 Method for chemical analysis of biological materials
11/13/2003WO2003092592A2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/13/2003WO2003092582A2 Chimeric ebola virus envelopes and uses therefor
11/13/2003WO2003070174A3 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
11/13/2003WO2003045310A3 Digital assay
11/13/2003WO2003040689A3 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
11/13/2003WO2003031459A3 Modulation of the expression of genes dependent on stat-1
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003028536A3 Methods for diagnosing and treating heart disease
11/13/2003WO2003027316A3 Methods of using 33751, a human potassium channel family member
11/13/2003WO2002083920A3 Nucleic acid sequences useful in the detection and treatment of various cancers
11/13/2003WO2002072888A3 Polymorphisms in the human cmoat gene and uses thereof
11/13/2003WO2002062825A3 Detection of polymorphisms in the human 5-lipoxygenase gene
11/13/2003US20030212267 Synthesis of sulfurized oligonucleotides
11/13/2003US20030212266 Growth arrest homeobox gene
11/13/2003US20030212032 Oligonucleotide N3'→P5' thiophosphoramidates: their synthesis and use
11/13/2003US20030212023 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta
11/13/2003US20030212020 Antisense modulation of macrophage migration inhibitory factor expression
11/13/2003US20030212019 Hybrid nucleic acid; anticancer agents
11/13/2003US20030212018 Antisense modulation of mekk2 expression
11/13/2003US20030212017 Antisense modulation of farnesyl transferase beta subunit expression
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
1 ... 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 ... 899